We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
In the latest close session, Albemarle (ALB - Free Report) was up +2.39% at $189.86. The stock outpaced the S&P 500's daily gain of 1.18%. At the same time, the Dow added 0.66%, and the tech-heavy Nasdaq gained 1.96%.
The stock of specialty chemicals company has risen by 14.15% in the past month, leading the Basic Materials sector's gain of 6.79% and the S&P 500's gain of 3.93%.
The investment community will be paying close attention to the earnings performance of Albemarle in its upcoming release. The company is slated to reveal its earnings on May 6, 2026. The company is forecasted to report an EPS of $0.78, showcasing a 533.33% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $1.28 billion, up 18.91% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $8.15 per share and revenue of $5.61 billion, which would represent changes of +1131.65% and +9.14%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Albemarle currently has a Zacks Rank of #3 (Hold).
In terms of valuation, Albemarle is currently trading at a Forward P/E ratio of 22.75. This signifies a premium in comparison to the average Forward P/E of 19.03 for its industry.
Investors should also note that ALB has a PEG ratio of 1.42 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. Chemical - Diversified stocks are, on average, holding a PEG ratio of 1.77 based on yesterday's closing prices.
The Chemical - Diversified industry is part of the Basic Materials sector. Currently, this industry holds a Zacks Industry Rank of 212, positioning it in the bottom 14% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Albemarle (ALB) Laps the Stock Market: Here's Why
In the latest close session, Albemarle (ALB - Free Report) was up +2.39% at $189.86. The stock outpaced the S&P 500's daily gain of 1.18%. At the same time, the Dow added 0.66%, and the tech-heavy Nasdaq gained 1.96%.
The stock of specialty chemicals company has risen by 14.15% in the past month, leading the Basic Materials sector's gain of 6.79% and the S&P 500's gain of 3.93%.
The investment community will be paying close attention to the earnings performance of Albemarle in its upcoming release. The company is slated to reveal its earnings on May 6, 2026. The company is forecasted to report an EPS of $0.78, showcasing a 533.33% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $1.28 billion, up 18.91% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $8.15 per share and revenue of $5.61 billion, which would represent changes of +1131.65% and +9.14%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Albemarle currently has a Zacks Rank of #3 (Hold).
In terms of valuation, Albemarle is currently trading at a Forward P/E ratio of 22.75. This signifies a premium in comparison to the average Forward P/E of 19.03 for its industry.
Investors should also note that ALB has a PEG ratio of 1.42 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. Chemical - Diversified stocks are, on average, holding a PEG ratio of 1.77 based on yesterday's closing prices.
The Chemical - Diversified industry is part of the Basic Materials sector. Currently, this industry holds a Zacks Industry Rank of 212, positioning it in the bottom 14% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.